# FDA Inspection 1030331 - Takeda Manufacturing Singapore Pte. Ltd. - September 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/takeda-manufacturing-singapore-pte-ltd/c6116b98-e27b-4e9e-aaa6-709e39a95911
Source feed: FDA_Inspections

> FDA Inspection 1030331 for Takeda Manufacturing Singapore Pte. Ltd. on September 29, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1030331
- Company Name: Takeda Manufacturing Singapore Pte. Ltd.
- Inspection Date: 2017-09-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1278679 - 2025-08-15](https://www.keypedia.com/records/fda_inspections/takeda-manufacturing-singapore-pte-ltd/46af7a29-8f76-43e2-8636-6c1f6b46fcb8)
- [FDA Inspection 1192281 - 2022-11-18](https://www.keypedia.com/records/fda_inspections/takeda-manufacturing-singapore-pte-ltd/3303fe8a-2500-4619-a4d6-60d725d2299a)
- [FDA Inspection 1084876 - 2018-12-07](https://www.keypedia.com/records/fda_inspections/takeda-manufacturing-singapore-pte-ltd/92f08dfd-5577-42b5-b692-9efcab55b5d4)

Company: https://www.keypedia.com/companies/takeda-manufacturing-singapore-pte-ltd/4ae048ca-a89e-47c7-b5a2-60d372157742

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d